INMB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - INmune Bio Inc

Watchlist Manager

Watchlist

Price: 1.72 USD -6.52% Market Closed

Market Cap: $45.7m

	INmune Bio Inc NASDAQ:INMB	US
	Neste Oyj F:NEF	FI
	Dabur India Ltd BSE:500096	IN
	Orthex Oyj F:4QU	FI
C	Cellectis SA SWB:ZVA	FR

Profitability Summary

INmune Bio Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-61.738%

Negative 3Y Average Operating Margin

-76.417%

Declining Operating Margin

-8.934% > -61.738%

Negative Net Margin

-91.866%

Negative 3Y Average Net Margin

-81.377%

Declining Net Margin

-9.172% > -91.866%

Negative Free Cash Flow Margin

-47.248%

Negative 3Y Average Free Cash Flow Margin

-54.712%

Declining Free Cash Flow Margin

-4.617% > -47.248%

Negative ROE

-165%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-360%

Declining ROIC

-117% > -520%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.